[1] Mine H,Emura H,Miyamoto M,et al.High throughPut screening of 16 million serologically negative blood donors for hePatitis B virus,hePatitis C virus and human immunodeficiency virus tyPe-1 by nucleic acid testing with sPecific and sensitive multiPlex reagent in JaPan[J].J Virol Methods,2003,112(1-2):145-151. [2] Hourfar M K., Jork C, Schottsted V,et al. ExPerience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blooddonations for human immunodeficiency virus-1, hePatitis C virus, and hePatitis B virus[J]. Transfusion, 2008,48(8):1558-1566. [3] Nübling C. Micha, Heiden Margarethe, Chudy Michael, et al. ExPerience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions[J]. Transfusion, 2009,49(9):1850-1858. [4] Stramer SL, Wend U, Candotti D, et al. Nucleic Acid Testing to Detect HBV Infection in Blood Donors[J]. N Engl J Med, 2011,364(3):236-247. [5] Taira R,Satake Masahiro,Momose S,et al. Residual risk of transfusion-transmitted hePatitis B virus(HBV) infection caused blood comPonents derived from donors with occult HBV infection in JaPan[J].T ransfusion ,2013, 53(7):1393-1404. [6] 周国平 王迅 任亚娜,等. 血液筛查策略的选择要因地制宜[J]. 中国输血杂志, 2015, 28(1):108-110. [7] 邹峥嵘,周国平,朱永明. 血站血液集中化检测的实践与思考[J]. 中国输血杂志, 2014,27(11):1085-1087. [8] 白玉,常卫红.美国应用核酸检测筛查血液的历程和现状[J].国际生物制品学杂志,2009,32(2):101-105. [9] 任芙蓉.核酸检测技术在国内外血液筛查中的应用[J].北京医学,2008,30(8):561-564. [10] 陈兴智,许建荣,吴敬林,等. 血液标本集中检测提高输血安全性研究[J]. 检验医学与临床, 2014,11(3): 299-301. [11] 吴丹霄,吴亚玲,吕杭军.核酸检测在献血筛查中的应用[J].浙江预防医学,2015,27(5):501-503. [12] 吕蓉,盛琪琪,赵阳,等. 核酸检测技术在安徽省血液中心筛查种的应用分析[J].安徽医学,2014,35(5):572-573. [13] 柯苑,赵静,马成平,等.核酸检测技术在献血人员血液筛查中的应用[J].检验医学与临床志,2014,11(20):2858-2859. [14] 段勇 ,郭逸 ,叶世辉. 病毒核酸检测技术在西安地区血液筛查中的应用分析[J].中国输血杂志, 2014,27(8):842-844). [15] 张妍,朱海峰,孙波,等. 核酸检测技术在血液筛查中的应用及分析[J] . 中国输血杂志, 2012,25(12):1298-1300. [16] 16 黎蕾. 献血者中的隐匿性HBV感染[J].中国输血杂志,2010,23(10):905-906. [17] 周国平,谢云峥,王迅,等. 做好假反应性献血者归队是血站的责任[J]. 中国输血杂志, 2014,27(10):1079-1082. |